Listen Score
LS 25
Global Rank
TOP 10%

ABOUT THIS PODCAST 🔗

Update frequency:
weekly
Average audio length:
24 minutes
Guest interviews
English
United States
360 episodes
since Sept. 14, 2018
episodic

AUDIENCE OF THIS PODCAST 🔗

~88.42% of listeners are from United States.
🇺🇸
US
88.42%
🇨🇦
CA
6.01%
🇵🇰
PK
2.31%
🇬🇧
GB
1.85%
🇩🇪
DE
0.46%
🇵🇭
PH
0.46%
🇨🇭
CH
0.46%
Others
0.03%
* Data source: directly measured on Listen Notes. real-time

LATEST EPISODE 🔗

Even the most promising innovation still depends on strong governance, resilient operations, and confidence in sensitive data. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Robbie Tyrie, founder and managing director of Torridon Cyber, for a conversation on cybersecurity whe…

SEARCH PAST EPISODES

Search past episodes of pharmaphorum Podcast.

PREVIOUS EPISODES

Industry is using AI to surface hidden patterns and accelerate decision-making in high-pressure launch environments. In a new pharmaphorum podcast, host Nicole Raleigh speaks with Jason Smith, CTO of AI and analytics at Within3, for a conversation on data-fuelled agile launches and smarter decisio…
Bioconvergence is a multidisciplinary research and development approach that merges technologies from biology, engineering, and computation, providing solutions in medicine, food, agriculture, manufacturing, climate, and more. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Sh…
Artificial intelligence is dramatically transforming the landscape for every part of pharma. One area where AI is both essential to implement and important to get right is pharmacovigilance, the group concerned with monitoring and maintaining patient safety.   In today's pharmaphorum podcast, spo…
Earlier this year, the FDA released draft guidance endorsing Bayesian methods and simulation-based evidence in clinical trials in a significant shift in how regulators think about predictive medicine.  In a new pharmaphorum podcast, Dr Irina Babina, CEO of oncology R&D platform Concr, discusse…
*This episode of the pharmaphorum podcast is brought to you in association with Klick Health* Europe continues to offer major life sciences advantages: deep scientific talent, strong clinical expertise, mature research infrastructure, and significant manufacturing capability. Indeed, biotech compa…
*This episode of the pharmaphorum podcast is brought to you in association with Klick Health* When it comes to digital innovation and AI, consideration of using and implementing such responsibly and ethically ever more becomes forefront. But how can pharma lead the way in ethical AI and trust-driv…
Public demand for prevention is surging, with 33.6 million people now using the NHS App, yet, NHS leaders say the digital infrastructure required to deliver prevention at scale isn’t in place. In a new episode of the podcast, pharmaphorum spoke with James Davis, a healthcare expert at PA Consultin…
For a variety of reasons, early stage clinical trials have been moving out of the United States more and more over the past few years, as companies pursue savings and lighter regulatory burden in places like China and Australia. The industry has long urged the US government to take some action to m…
Chronic liver disease affects around 1.5 billion people globally. As understanding of liver disease improves, outcomes are increasingly determined by how early patients are identified, not just what therapies are available. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Lee L…
Disclaimer: The podcast and artwork embedded on this page are from pharmaphorum, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.